Preclinical metabolism and disposition of [ 14 C]GFH009, a novel selective CDK9 inhibitor
Year: 2024
Type: article
Source: Xenobiotica
Institution: Genfleet Therapeutics (Shanghai) Inc. (China)
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4404244188
